AstraZeneca Pharma India Ltd on Wednesday said it has received an approval from the Drug Controller General of India (DCGI) for the cancer drug trastuzumab deruxtecan for treatment of metastatic breast cancer.
The company said it has been granted approval to import and market trastuzumab deruxtecan used in the treatment of select "HER-2 positive" breast cancer.
"The India approval is based on a global, head-to-head, randomised, open label, registrational Phase III trial DESTINY Breast 03. Globally, trastuzumab deruxtecan is approved in more than 40 countries, including the US, for the treatment of adult patients with unresectable or metastatic HER2-positive breast cancer," AstraZeneca Pharma India said in a statement.
HER2 is a form of growth-promoting protein expressed on the surface of multiple tumours, including breast, gastric, lung and colorectal cancers, and is one of the biomarkers expressed in breast cancer tumours, it added.
"India's approval of trastuzumab deruxtecan marks a significant clinical advancement allowing us to help more patients across the HER2 spectrum," AstraZeneca India Country President and Managing Director Sanjeev Panchal said.
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
Featured Video Of The Day
Tomatoes Thrown, Protest Outside Allu Arjun's Home Over Stampede Death
After Pharma Firm's Huge Eye Drop Claim, Regulator Withdraws Permission Only Processing Charges To Be Levied For Procuring Blood At Hospitals, Blood Banks: Drug Regulator Sale Of False Version Of 2 Drugs To Be Monitored In India After WHO Alert Pics: Rahul Gandhi's Family Lunch At Iconic Delhi Restaurant 3 Khalistani Terrorists, Who Attacked Punjab Cops, Killed In UP Encounter Donald Trump Appoints Indian-American, Elon Musk Aide As AI Advisor "Ran For My Life": Gurgaon Woman Shares Traumatic Experience With Ola Cab "Affecting Reputation": Malaysia Airlines Grounds New Airbus Jet Over Safety 3 Khalistani Terrorists, Who Attacked Punjab Cops, Killed In UP Encounter Track Latest News Live on NDTV.com and get news updates from India and around the world.